Skip to content

Effect of calcitonin in frozen shoulder treatment

Evaluation of response to calcitonin treatment in patients with frozen shoulder in selected hospitals of Islamic Azad University of Medical Sciences, Tehran in 2022

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220523054971N1
Enrollment
64
Registered
2023-04-03
Start date
2021-12-19
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frozen shoulder. Adhesive capsulitis of unspecified shoulder

Interventions

Intervention 1: Intervention group: Patients receiving calcitonin nasal spray in addition to common treatments
In this group of patients, intranasal calcitonin spray of 200 units is prescribed along with current common treatments such as aspirin, ibuprofen, intra-articular injection of steroids and physical th
the effect of this treatment method is checked from the time of administration to 6 weeks later in the form of face-to-face interview or phone call and compared with the results of the control group.
This group of patients receives current common treatments such as aspirin, ibuprofen, intra-articular injection of steroids and physiotherapy, and the results of the intervention group are compared wi

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with a clinical diagnosis of frozen shoulder Patients symptoms including limitation in all active and passive movements of the shoulder joint in all directions Patients with relatively severe pain Patients with reduction in the range of motion of the shoulder Definite confirmation of the diagnosis with the help of MRI of the shoulder joint

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain changes with visual analogue scale(VAS). Timepoint: 6 weeks after receiving calcitonin nasal spray. Method of measurement: Visual analogue scale.;Changes in the range of motion with the angle scale in degrees. Timepoint: 6 weeks after receiving calcitonin nasal spray. Method of measurement: Degrees of angle.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Afshin Farhadi

Islamic Azad University

afshinfarhadi53@gmail.com+98 21 5534 6550

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026